Literature DB >> 17641862

[Aggressive course of a malignant alveolar soft tissue sarcoma].

T Strunk1, P J Bastian, J Ellinger, K Biermann, S C Müller.   

Abstract

Alveolar soft part sarcoma is a rare soft tissue tumor. Most patients who are affected by this sarcoma are between 15 and 35 years old. The tumor is characterized by its uncommon location of metastasis. Publications concerning this sarcoma subform are rare and the best therapeutic procedure is not yet clear. Surgical excision, radiation and chemotherapy are performed, whereas complete surgical excision achieves the best results in long-term follow-up. We report a patient's history who rapidly died of his sickness despite the low initial tumor stage.

Entities:  

Mesh:

Year:  2007        PMID: 17641862     DOI: 10.1007/s00120-007-1509-0

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  8 in total

1.  New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada.

Authors:  P Therasse; S G Arbuck; E A Eisenhauer; J Wanders; R S Kaplan; L Rubinstein; J Verweij; M Van Glabbeke; A T van Oosterom; M C Christian; S G Gwyther
Journal:  J Natl Cancer Inst       Date:  2000-02-02       Impact factor: 13.506

2.  Alveolar soft-part sarcomas; structurally characteristic tumors of uncertain histogenesis.

Authors:  W M CHRISTOPHERSON; F W FOOTE; F W STEWART
Journal:  Cancer       Date:  1952-01       Impact factor: 6.860

3.  Clinical presentation, treatment, and outcome of alveolar soft part sarcoma in children, adolescents, and young adults.

Authors:  Mark L Kayton; Paul Meyers; Leonard H Wexler; William L Gerald; Michael P LaQuaglia
Journal:  J Pediatr Surg       Date:  2006-01       Impact factor: 2.545

4.  Role of radiotherapy and chemotherapy in the risk of secondary leukaemia after a solid tumour in childhood.

Authors:  Nadia Haddy; Marie Cécile Le Deley; Akhtar Samand; Ibrahima Diallo; Sylvie Guérin; Catherine Guibout; Odile Oberlin; Mike Hawkins; Jean-Michel Zucker; Florent de Vathaire
Journal:  Eur J Cancer       Date:  2006-09-11       Impact factor: 9.162

5.  A proposed explanation for female predominance in alveolar soft part sarcoma. Noninactivation of X; autosome translocation fusion gene?

Authors:  Xiangdong Bu; Leslie Bernstein
Journal:  Cancer       Date:  2005-03-15       Impact factor: 6.860

Review 6.  Chemotherapy in alveolar soft part sarcomas. What do we know?

Authors:  P Reichardt; T Lindner; D Pink; P C Thuss-Patience; A Kretzschmar; B Dörken
Journal:  Eur J Cancer       Date:  2003-07       Impact factor: 9.162

7.  Alveolar soft part sarcoma: clinical course and patterns of metastasis in 70 patients treated at a single institution.

Authors:  C A Portera ; V Ho; S R Patel; K K Hunt; B W Feig; P M Respondek; A W Yasko; R S Benjamin; R E Pollock; P W Pisters
Journal:  Cancer       Date:  2001-02-01       Impact factor: 6.860

8.  Prognostic significance of staging factors of the UICC staging system in childhood rhabdomyosarcoma: a report from the Intergroup Rhabdomyosarcoma Study (IRS-II).

Authors:  W Lawrence; E A Gehan; D M Hays; M Beltangady; H M Maurer
Journal:  J Clin Oncol       Date:  1987-01       Impact factor: 44.544

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.